« BackInternational Journal of Radiation Oncology * Biology * Physics
Article in Press

Applying a Hypoxia-Incorporating TCP Model to Experimental Data on Rat Sarcoma

  • Ruggero Ruggieri, Ph.D.

      Affiliations

    • Department of Radiation Oncology, S. Cuore—don Calabria Hospital, Negrar (VR), Italy
    • Corresponding Author InformationReprint requests to: Ruggero Ruggieri, Ph.D., Via Valdonega 22, 37128 Verona (VR), Italy. Tel: (+39) 333-1134355; Fax: (+39) 45-6014624
  • ,
  • Nadejda Stavreva, Ph.D.

      Affiliations

    • Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC), Italy
  • ,
  • Stefania Naccarato, Ph.D.

      Affiliations

    • Department of Radiation Oncology, S. Cuore—don Calabria Hospital, Negrar (VR), Italy
  • ,
  • Pavel Stavrev, Ph.D.

      Affiliations

    • Medical Physics Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC), Italy

Received 12 April 2011; received in revised form 18 September 2011; accepted 4 October 2011. published online 23 January 2012.
Corrected Proof

Purpose

To verify whether a tumor control probability (TCP) model which mechanistically incorporates acute and chronic hypoxia is able to describe animal in vivo dose–response data, exhibiting tumor reoxygenation.

Methods and Materials

The investigated TCP model accounts for tumor repopulation, reoxygenation of chronic hypoxia, and fluctuating oxygenation of acute hypoxia. Using the maximum likelihood method, the model is fitted to Fischer-Moulder data on Wag/Rij rats, inoculated with rat rhabdomyosarcoma BA1112, and irradiated in vivo using different fractionation schemes. This data set is chosen because two of the experimental dose–response curves exhibit an inverse dose behavior, which is interpreted as due to reoxygenation. The tested TCP model is complex, and therefore, in vivo cell survival data on the same BA1112 cell line from Reinhold were added to Fischer-Moulder data and fitted simultaneously with a corresponding cell survival function.

Results

The obtained fit to the combined Fischer-Moulder-Reinhold data was statistically acceptable. The best-fit values of the model parameters for which information exists were in the range of published values. The cell survival curves of well-oxygenated and hypoxic cells, computed using the best-fit values of the radiosensitivities and the initial number of clonogens, were in good agreement with the corresponding in vitro and in situ experiments of Reinhold. The best-fit values of most of the hypoxia-related parameters were used to recompute the TCP for non–small cell lung cancer patients as a function of the number of fractions, TCP(n).

Conclusions

The investigated TCP model adequately describes animal in vivo data exhibiting tumor reoxygenation. The TCP(n) curve computed for non–small cell lung cancer patients with the best-fit values of most of the hypoxia-related parameters confirms previously obtained abrupt reduction in TCP for n < 10, thus warning against the adoption of severely hypofractionated schedules.

Keywords: TCP, Acute hypoxia, Chronic hypoxia, Reoxygenation, SBRT

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Conflicts of interest: none.

PII: S0360-3016(11)03377-3

doi:10.1016/j.ijrobp.2011.10.015

« BackInternational Journal of Radiation Oncology * Biology * Physics